GlassScriptPhysician profile
Kanani Floyd
NPI 1154624013
$931.36
in general payments reported to CMS, 2019-2025
18 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $131 · 2023: $134 · 2024: $260 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595 · Entertainment: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.04 |
| Entertainment | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $179.01 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Lilly USA, LLC | $123.34 | 2021-2025 | Kisunla, Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $93.50 | 2024-2025 | Rexulti |
| Amgen INC. | $88.82 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Pfizer INC. | $68.73 | 2024 | |
| Exact Sciences Corporation | $62.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $59.35 | 2021-2024 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $54.79 | 2024-2025 | Caplyta |
| Novo Nordisk INC | $33.61 | 2022 | |
| Astellas Pharma US INC | $28.22 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.14 | 2021 | |
| Phadia US INC. | $20.97 | 2023 | Immunocap |
| Linus Health, INC. | $19.11 | 2023 | |
| Horizon Therapeutics Plc | $17.13 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.96 | 2024 | Airsupra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.31 | 2021 | |
| Optos, INC. | $13.60 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanani Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.